Erratum to silencing of DHX32 increases the proliferation of liver cancer cells
Erratum

Erratum to silencing of DHX32 increases the proliferation of liver cancer cells

Editorial Office

Translational Cancer Research

Correspondence to: Editorial Office. Translational Cancer Research. Email: tcr@amepc.org.

Submitted Jun 14, 2022. Accepted for publication Sep 09, 2022.

doi: 10.21037/tcr-22-2239


Erratum to: Transl Cancer Res 2020;9:1833-42

In the March 2020 issue of Translational Cancer Research, the paper “Silencing of DHX32 increases the proliferation of liver cancer cells” (doi: 10.21037/tcr.2020.02.35) by Dr. Cai et al. (1) was published with some errors in the authorship. The fourth author and corresponding author, Zhong Ying Zhang was mistakenly listed as the corresponding author of this article and Zhong Ying Zhang asked to remove her name from the author list. The correct authorship is listed as follows:

Min-Jing Cai1,2#, Jian-Hui Zhu1,2#, Jian-Quan He3#, Xian-Ming Liang1,2

1Center of Clinical Laboratory, Zhongshan Hospital, School of Medicine, Xiamen University, Xiamen, China; 2Institute of Infectious Disease, School of Medicine, Xiamen University, Xiamen, China; 3Department of Rehabilitation, Zhongshan Hospital, School of Medicine, Xiamen University, Xiamen, China

Contributions: (I) Conception and design: XM Liang; (II) Administrative support: XM Liang; (III) Provision of study materials or patients: All authors; (IV) Collection and assembly of data: All authors; (V) Data analysis and interpretation: MJ Cai, JH Zhu, JQ He, XM Liang; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.

These authors contributed equally to this work.

Correspondence to: Dr. Xian-Ming Liang. Center of Clinical Laboratory, Zhongshan Hospital, School of Medicine, Xiamen University, No. 201-209, Hubin South Road, Xiamen 361004, China. Email: 178292958@qq.com.

The authors regret the error and all inconveniences caused.

Click here to view the updated version of the article.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


References

  1. Cai MJ, Zhu JH, He JQ, et al. Silencing of DHX32 increases the proliferation of liver cancer cells. Transl Cancer Res 2020;9:1833-42. [Crossref] [PubMed]
Cite this article as: Editorial Office. Erratum to silencing of DHX32 increases the proliferation of liver cancer cells. Transl Cancer Res 2022;11(11):4218-4219. doi: 10.21037/tcr-22-2239

Download Citation